Recent Finacing
Recent Raise
Sensei Biotherapeutics is a clinical-stage biopharma developing ImmunoPhage bacteriophage-based cancer immunotherapies, leveraging a GMP-grade Phortress library for customizable off‑the‑shelf antigen cocktails and advancing SNS-301 and preclinical programs.
